A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia.
about
MYC, Metabolism, and CancerRedefining ALL classification: toward detecting high-risk ALL and implementing precision medicineEmerging concepts of epigenetic dysregulation in hematological malignanciesThe relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemiaThe PIAS-like Coactivator Zmiz1 Is a Direct and Selective Cofactor of Notch1 in T Cell Development and LeukemiaControlling the Master: Chromatin Dynamics at the MYC Promoter Integrate Developmental SignalingEfficient chromosomal-scale DNA looping in Escherichia coli using multiple DNA-looping elementsSystematic mapping of functional enhancer-promoter connections with CRISPR interference.Mice deficient of Myc super-enhancer region reveal differential control mechanism between normal and pathological growth.MYC Deregulation in Primary Human Cancers.Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers.SEA: a super-enhancer archive.Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers.The role of Notch receptors in transcriptional regulationDirect ChIP-Seq significance analysis improves target prediction.High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer.Super Enhancers in Cancers, Complex Disease, and Developmental Disorders.Histone demethylase KDM2B regulates lineage commitment in normal and malignant hematopoiesis.Modulation of tissue repair by regeneration enhancer elements.Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia.Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case.MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs.Epigenetics of hematopoiesis and hematological malignancies.Small genomic insertions form enhancers that misregulate oncogenesMYC in Regulating Immunity: Metabolism and Beyond.c-Myc-Induced Survivin Is Essential for Promoting the Notch-Dependent T Cell Differentiation from Hematopoietic Stem Cells.Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands.Genomics in acute lymphoblastic leukaemia: insights and treatment implications.Drugging Chromatin in Cancer: Recent Advances and Novel Approaches.Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.Genome-wide identification and characterization of Notch transcription complex-binding sequence-paired sites in leukemia cells.Oncogenic Notch signaling in T-cell and B-cell lymphoproliferative disorders.Enhancer deregulation in cancer and other diseases.Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.Deregulation of the non-coding genome in leukemia.ChIP-seq in studying epigenetic mechanisms of disease and promoting precision medicine: progresses and future directions.Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia.Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
P2860
Q26783555-B4455E97-F044-4429-967D-BAD268CE23A3Q26864460-98EB64FF-BA7F-49DC-86A0-9163DE3BB297Q28074522-C523E776-A218-448F-ACA5-CACD5D6E5458Q28075211-03DE1616-7A65-49BC-BB14-DA9A72ED23EBQ28115221-0E220E49-4EF1-418E-8B7A-13A4B188EB56Q33608508-9DD3CFC0-33E4-4048-9739-575C051AAC61Q33701424-A0AF4529-C92E-460E-9A6A-BEFCACBBD497Q33709312-CAC8D43B-6626-442C-B45E-5BDC85768F9CQ33769766-6B362819-F134-4171-9ADD-338A83AF7591Q33836755-7A555570-C3C0-4F9A-BC63-02BFE00C9793Q34468271-47130F06-043B-4AF8-80EE-5EB30F55783EQ34502036-1C9E04F0-179F-4338-B5C8-153CA45F9915Q34504751-0F7F66FE-3364-4701-8E54-34B79185FC82Q35640825-268FCE1D-E83F-4523-93C0-AFA4EBE7977FQ35651924-A0FDEFA8-68DC-43AE-99E3-1084AC7C35E5Q36178314-0B0F2073-A4DE-4365-85BA-18B145DE9DF7Q36378105-89F23E75-DFDA-44FC-9CD8-D409968C9F5DQ36401138-DED34E7B-937F-40F9-9D24-D27B2F0C675FQ36618609-1952531B-1121-46A6-A46C-FDCBE59BCC97Q36832920-D4A43908-0AFA-46B6-9E84-FFC1B91AE13AQ36837426-EE92B6FE-CA18-493E-A933-EFD7E7EE9A2FQ36851425-ED80FAFC-947A-4C88-A775-535515D1824DQ37217649-FAA706FF-FA44-4B91-8A15-37C9175A0B05Q37343797-F932C235-9EA3-469E-8742-8B3CB2F9D30CQ37642694-BAF72BA2-0D0E-4F89-8806-53EC035181B7Q37724101-EACFBF2B-1C80-4151-9D84-DFF83BFD7CBDQ37724122-7BC2AB2D-BE61-4EBC-A4B5-92C3C957F410Q37730667-4086156E-5E25-4E56-A6E6-A9DBAEDF0CE7Q38381463-F8A25DA9-EDBD-46D8-A42B-EB1180E3E565Q38641649-199E63B3-0665-431A-8B38-8852EED77B87Q38666159-5C53D4CA-83FC-477E-BCC6-489D5DB827EEQ38774751-841269BF-0167-41EF-BD42-68FD98364DDEQ38808041-0964EF03-62F2-4C2A-8CB8-D360FC4515F1Q38823047-E449D9EF-81AD-417B-AAAD-CB117FA2E729Q38826989-C0F10FB0-3813-40ED-A981-35BE6494A5F5Q38847636-6E33D185-77A8-4D3F-B9B5-D8A49D4C30ADQ38848335-FE0623C3-097D-4969-8998-286909DD9A83Q38851252-3A1F3C91-CFC9-4D60-B6FD-26FF83667952Q38860425-57956228-3588-4EC3-9C12-E0325E004C86Q38954118-9785569A-E3E8-43CB-AD43-1D7BD6D6FBD5
P2860
A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A NOTCH1-driven MYC enhancer p ...... acute lymphoblastic leukemia.
@ast
A NOTCH1-driven MYC enhancer p ...... acute lymphoblastic leukemia.
@en
A NOTCH1-driven MYC enhancer p ...... acute lymphoblastic leukemia.
@nl
type
label
A NOTCH1-driven MYC enhancer p ...... acute lymphoblastic leukemia.
@ast
A NOTCH1-driven MYC enhancer p ...... acute lymphoblastic leukemia.
@en
A NOTCH1-driven MYC enhancer p ...... acute lymphoblastic leukemia.
@nl
prefLabel
A NOTCH1-driven MYC enhancer p ...... acute lymphoblastic leukemia.
@ast
A NOTCH1-driven MYC enhancer p ...... acute lymphoblastic leukemia.
@en
A NOTCH1-driven MYC enhancer p ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P356
P1433
P1476
A NOTCH1-driven MYC enhancer p ...... acute lymphoblastic leukemia.
@en
P2093
Adolfo A Ferrando
Agnieszka A Wendorff
Daniel Herranz
David Llobet-Navás
Emmanuelle Clappier
Jean Soulier
Laura Belver
Mireia Castillo-Martin
Stephanie A Schnell
P2860
P2888
P304
P356
10.1038/NM.3665
P407
P577
2014-09-07T00:00:00Z